BRPI0816952A2 - Composição para tratar ou contralar uma infecção em um indivíduo, e, usos de uma fluoroquinolona e de uma combinação - Google Patents

Composição para tratar ou contralar uma infecção em um indivíduo, e, usos de uma fluoroquinolona e de uma combinação

Info

Publication number: BRPI0816952A2
Authority: BR; Brazil
Prior art keywords: fluoroquinolone; counteracting; infection; treating; individual
Prior art date: 2007-09-21

Application number

Other languages

English (en)

Inventor

Srini Venkatesh

Hongna Wang

Erning Xia

Matthew Scott Jonasse

Original Assignee

Bausch & Lomb

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-21

Filing date

2008-09-10

Publication date

2015-03-24

2008-09-10 Application filed by Bausch & Lomb filed Critical Bausch & Lomb

2015-03-24 Publication of BRPI0816952A2 publication Critical patent/BRPI0816952A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0816952 2007-09-21 2008-09-10 Composição para tratar ou contralar uma infecção em um indivíduo, e, usos de uma fluoroquinolona e de uma combinação BRPI0816952A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US97414107P	2007-09-21	2007-09-21
PCT/US2008/075754 WO2009042395A1 (en)	2007-09-21	2008-09-10	Compositions comprising quinolone and methods for treating or controlling infections

Publications (1)

Publication Number	Publication Date
BRPI0816952A2 true BRPI0816952A2 (pt)	2015-03-24

Family

ID=39929635

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0816952 BRPI0816952A2 (pt)	2007-09-21	2008-09-10	Composição para tratar ou contralar uma infecção em um indivíduo, e, usos de uma fluoroquinolona e de uma combinação

Country Status (10)

Country	Link
US (2)	US20090082337A1 (pt)
EP (1)	EP2205246A1 (pt)
JP (1)	JP2010540442A (pt)
KR (1)	KR20100045513A (pt)
CN (1)	CN101801387A (pt)
AU (1)	AU2008305341B9 (pt)
BR (1)	BRPI0816952A2 (pt)
CA (2)	CA2698221C (pt)
MX (1)	MX2010002957A (pt)
WO (1)	WO2009042395A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0819175A2 (pt) *	2007-11-05	2015-05-05	Bausch & Lomb	Composição farmacêutica oftálmica, e, método para proporcionar disponibilidade estendida de um componente farmacêutico em um ambiente ocular de um indivíduo, e, uso de pelo menos um componente farmacêutico, pelo menos um material imiscível em água e opcionalmente um composto modificador de viscosidade
UA111147C2 (uk) *	2009-11-11	2016-04-11	Байєр Б.В.	Способи та композиції для лікування або профілактики зовнішнього отиту
AU2013208252B2 (en) *	2012-01-10	2016-03-03	Entrx LLC	Otic formulations, methods and devices
US20140377356A1 (en) *	2013-06-19	2014-12-25	Professional Compounding Centers Of America (Pcca)	Inhalation Composition for Treating Respiratory Tract Infections
US20150335704A1 (en) *	2014-05-23	2015-11-26	Imprimis Pharmaceuticals, Inc.	Pharmaceutical compositions comprising gels and methods for fabricating thereof
CN104224691B (zh) *	2014-09-19	2018-01-05	南京优科生物医药研究有限公司	一种盐酸莫西沙星的外用制剂及其制备方法
US9393243B1 (en)	2015-07-14	2016-07-19	Nilesh Parikh	Topical Ciprofloxacin compositions
AU2019263302C1 (en) *	2018-05-01	2024-10-31	Chibi, Inc.	Liquid depot for non-invasive sustained delivery of agents to the eye
KR20210061336A (ko)	2018-07-27	2021-05-27	아페르타 바이오사이언시스 엘엘씨	모낭충으로 유발된 안구 및 안면 증상의 치료를 위한 스피노신 제제
GB201913068D0 (en) *	2019-09-10	2019-10-23	Helperby Therapeutics Ltd	Combination

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3049474A (en) *	1957-02-15	1962-08-14	Ici Ltd	Antibacterial compositions containing 1-methyl-6-nitro-4-quinolone-3-carboxylic acid or sodium salt thereof
JP2613139B2 (ja) *	1990-07-19	1997-05-21	エスエス製薬株式会社	キノロンカルボン酸誘導体
EP0601197A4 (en) *	1992-05-26	1994-10-26	Ss Pharmaceutical Co	DERIVATIVES OF 5-AMINOCHINOLONE CARBOXYLIC ACID AND ANTIBACTERIAL AGENTS CONTAINING IT AS AN ACTIVE INGREDIENT.
IL109626A0 (en) *	1993-05-15	1994-08-26	Abbott Lab	Stable quinolone and naphthydridine premix formulations
FR2706459B1 (fr) *	1993-06-17	1995-08-04	Bouchara Sa	Nouveaux dérivés quinoloniques, leur procédé d'obtention et les compositions pharmaceutiques qui en contiennent.
US6699492B2 (en) *	1999-03-31	2004-03-02	Insite Vision Incorporated	Quinolone carboxylic acid compositions and related methods of treatment
US6685958B2 (en) *	2001-04-25	2004-02-03	Insite Vision Incorporated	Quinolone carboxylic acid compositions and related methods of treatment
US8372814B2 (en) *	2004-06-07	2013-02-12	Ista Pharmaceuticals, Inc.	Ophthalmic formulations and uses thereof
CN101641100A (zh) *	2007-03-21	2010-02-03	博士伦公司	用于治疗、降低、改善或预防由抗细菌药物抗性的细菌引起的感染的氟喹诺酮类
US8173640B1 (en) *	2007-05-18	2012-05-08	Bausch & Lomb Incorporated	Compositions and methods for treating, reducing, ameliorating, or preventing infections

2008
- 2008-09-08 US US12/205,946 patent/US20090082337A1/en not_active Abandoned
- 2008-09-10 CN CN200880107873A patent/CN101801387A/zh active Pending
- 2008-09-10 MX MX2010002957A patent/MX2010002957A/es active IP Right Grant
- 2008-09-10 BR BRPI0816952 patent/BRPI0816952A2/pt not_active IP Right Cessation
- 2008-09-10 CA CA2698221A patent/CA2698221C/en not_active Expired - Fee Related
- 2008-09-10 EP EP08834408A patent/EP2205246A1/en not_active Withdrawn
- 2008-09-10 CA CA2790774A patent/CA2790774A1/en not_active Abandoned
- 2008-09-10 WO PCT/US2008/075754 patent/WO2009042395A1/en not_active Ceased
- 2008-09-10 JP JP2010525892A patent/JP2010540442A/ja active Pending
- 2008-09-10 KR KR1020107006047A patent/KR20100045513A/ko not_active Ceased
- 2008-09-10 AU AU2008305341A patent/AU2008305341B9/en not_active Ceased
2011
- 2011-06-24 US US13/167,836 patent/US20110251147A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2008305341A1 (en)	2009-04-02
CN101801387A (zh)	2010-08-11
KR20100045513A (ko)	2010-05-03
AU2008305341B9 (en)	2012-08-16
JP2010540442A (ja)	2010-12-24
CA2698221C (en)	2012-12-11
CA2698221A1 (en)	2009-04-02
CA2790774A1 (en)	2009-04-02
EP2205246A1 (en)	2010-07-14
MX2010002957A (es)	2010-04-07
AU2008305341B2 (en)	2012-02-16
US20110251147A1 (en)	2011-10-13
US20090082337A1 (en)	2009-03-26
WO2009042395A1 (en)	2009-04-02

Similar Documents

Publication	Publication Date	Title
BRPI0816952A2 (pt)	2015-03-24	Composição para tratar ou contralar uma infecção em um indivíduo, e, usos de uma fluoroquinolona e de uma combinação
BRPI1013705A2 (pt)	2016-04-05	compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BRPI0916235A2 (pt)	2018-03-13	composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv
BRPI0810956A2 (pt)	2015-09-08	"composição, método para controlar de modo preventivo ou curativo e uso da composição"
BRPI0818732A2 (pt)	2014-10-07	Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.
BRPI0908021A2 (pt)	2015-07-21	Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica
BRPI1008383A2 (pt)	2016-02-23	composto, composição farmacêutica, método para prevenir, inibir ou tratar uma condição, e, uso de um composto
BRPI1013984A2 (pt)	2018-06-19	composto , composição farmacêutica, método para tratamento ou profilaxia de uma doença ou condição, e, uso de um composto.
BRPI0815057A2 (pt)	2015-07-28	Composto, composição farmacêutica, e, método para tratar infecção.
CL2015002519A1 (es)	2017-03-24	Composiciones antimicrobiales y procedimientos de uso relacionados.
BRPI0816097A2 (pt)	2016-11-01	composição farmacêutica, método para tratar eritema em um paciente com rosácea, e, uso de uma composição.
BRPI0910503A2 (pt)	2015-09-29	compostos, composições farmacêuticas e respectivos usos.
BRPI0814941A2 (pt)	2014-09-30	Composição de tratamentode semente, e, método de tratamento de semente.
CL2007003495A1 (es)	2008-05-30	Compuestos derivados de heterociclos condensados sustituidos, inhibidores de la actividad de la akt; composicion farmaceutica; y uso para el tratamiento o prevencion del cancer.
BRPI0816175A2 (pt)	2015-02-24	Composições adequadas para tratamento de doença, distúrbio ou condição da espinha.
BRPI0820568A2 (pt)	2015-06-16	Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal
BRPI0822337A2 (pt)	2015-06-16	Folatos, composições e usos dos mesmos
BRPI1007379A2 (pt)	2016-02-16	composições e métodos para o tratamento ou a prevenção de infecções orais por e. coli
BR112013011968A2 (pt)	2016-08-30	composição farmacêutica, métodos de tratamento e usos da mesma
BRPI0915105A2 (pt)	2019-09-24	composto de 2,4'-biripidinila como inibidores da proteína cinase d úteis para o tratamento de ia insuficiência cardíaca e cancer
BRPI0907977A2 (pt)	2015-08-04	Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0911203A2 (pt)	2016-07-05	peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo.
BRPI0815591A2 (pt)	2015-03-03	Composto, composição farmacêutica, uso de um composto, e, método para tratar uma doença, condição ou distúrbio.
BRPI0916705A2 (pt)	2015-11-10	polipeptídeo isolado, polinucleotídeo isolado, composição farmacêutica, composição imunogênica, método para tratamento ou prevenção de tuberculose, e, usos de um polipeptídeo, e de um polinucleotídeo.
BRPI0907974A2 (pt)	2015-08-04	Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.